Delivery Order SPE2DE24D0021-SPE2D626F344M

The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $2,156 to Fisher Scientific Company L.L.C. on November 20, 2025, for the provision of BinaxNOW COVID-19 antigen testing kits. This is a fixed-price delivery order with economic price adjustment provisions, with an ultimate completion date of November 28, 2025. The contract carries no set-aside designation, indicating Fisher Scientific competed for this award in an open procurement environment. Performance will occur at Fisher Scientific's facility in Pittsburgh, Pennsylvania, where the company maintains its principal place of business and operates as a leading federal supplier of laboratory equipment, scientific products, and medical supplies.

This delivery order represents a routine procurement from Fisher Scientific's extensive federal contract portfolio supporting the Department of Defense's medical supply operations. Fisher Scientific has established itself as a preferred supplier to multiple federal agencies, including the Department of Veterans Affairs and various Department of Health and Human Services components, delivering specialized diagnostic equipment, laboratory supplies, and medical consumables. The relatively modest contract value and compressed performance timeline reflect the urgent operational need for COVID-19 diagnostic testing capabilities within the defense healthcare system. As a child contract under the company's broader federal contracting relationships, this award demonstrates the ongoing demand for diagnostic and testing supplies across the federal government's medical supply chain infrastructure.